Skip to content

Efficacy and Safety of Precut-EMR for Resecting of Colonic Polyp

Comparison Between EMR and Precut-EMR for Colorectal Polyp; Randomized Prospective Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04253990
Enrollment
0
Registered
2020-02-05
Start date
2016-05-31
Completion date
2017-06-30
Last updated
2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Polyps

Keywords

Colonic polyps, Colonoscopy

Brief summary

This study was attempted to determine the efficacy and complication of precut EMR comparing with convetional EMR for resecting of 10 \ 20 mm colon polyp through prospective, randomized controlled trial.

Detailed description

In general, a potential risk of advanced colorectal neoplasia is proportional with size. However, recent study report that occurence rate of advanced neoplasia in small polyp is 9 \ 10 %. And, incidence of interval cancer after screening colonoscopy was reported as 10 \ 27%. So We can suspect that complete resection of small polyp is important. Previous study recommended that endoscopic submucosal dissection (ESD) is a safe and effective procedure for treating colon polyp larger than 20 mm because of high complete resection rate and low recurrence rate. In contrast, endoscopic mucosal resection (EMR) is more recommended for resecting colon polyp smaller than 20 mm because of technical ease and low rate of complication. However, Complete resection rate of conventional EMR is 60 \ 70%. In case of incomplete resection, local recurrence rate is higher than complete resection. And In case of adenocarcinoma, specimen of piecemeal resection cannot be evaluated a depth of invasion and resection margin, and physician cannot decide a therapeutic plan. In precut-EMR, mucosal resection is performed after pre-incision around a polyp. When precut EMR of polyp \> 20 mm was performed in previous study, complete resection rate and en-bloc resection rate were higher and local recurrence rate was lower than conventional EMR. But, there is no study of comparsion precut EMR and conventional EMR for resecting colon polyp \< 20 mm. This study was attempted to determine the efficacy and complication of precut EMR comparing with convetional EMR through prospective, randomized controlled trial.

Interventions

PROCEDUREPrecut EMR

For treating of 10\ 20mm colon polyp, patient will be randomly divided into two groups, a Precut-EMR group and a EMR group. In Precut-EMR, endoscopist submucosally inject with saline around a polyp. Subsequently, circumferential incision/precutting was made with the tip of the snare around 2 mm outside the tumor. After that, the snare was positioned in the cut groove and tightend, and the tumor was resected using electrical current.

PROCEDUREConventional MER

EMR had been widely used technique. Endoscopist submucosally inject with saline around a polyp. After that, snare is positioned around a polyp, and polyp was resected using electrical current.

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients older than 20 years old who had 10\ 20 mm colon polyp and agreed to participate a research

Exclusion criteria

* Medication history of antiplatelet agent within a week of procedure. * Medical history of coagulopathy * More than American Society of Anesthesiology class III * Medical history of liver cirrhosis, chronic kidney disease, malignancy, inflammatory bowel disease, severe inflammatory disease. * pedunculated polyp and polyp with malignant potential.

Design outcomes

Primary

MeasureTime frame
Histologic complete resection ratebaseline ( enrollment of all planned patient)

Secondary

MeasureTime frame
Procedure timeprocedure
Complication such as perforation, bleedingbaseline ( enrollment of all planned patient)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026